What's new

Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Withdrawn

Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Withdrawn

Mar 12, 2025 - 17:04
 0
Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Withdrawn
Read More

Tags:

Previous Article

Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02...

Next Article

Orphan designation: Adeno-associated viral vector serotype rh10 containing the h...

Related Posts

Minutes of the CHMP meeting on 14-17 October 2024

Mar 7, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Saxenda, liraglutide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0468/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0

Herbal medicinal product: Valerianae aetheroleumArray, C: ongoing call for scientific data

Herbal medicinal product: Valerianae aetheroleumArray, ...

Feb 14, 2025  0